Clinical Trials Browser

Phase 1/2 × INDUSTRY × HER2-expressing Advanced Solid Tumors × Clear all

NCT06015048 2024-08-05

A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.

Phase 1/2 Recruiting

Other solid neoplasm

HER2-expressing Advanced Solid Tumors